Menu
Recruiting NCT06984809

Evaluation of the Invest in Play Program - a New Parent Intervention for Children With Problem Behavior

No phase Interventional Problem Behavior Attention Deficit and Disruptive Behavior Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Intervention.
Who it may be relevant to
Registry conditions: Problem Behavior, Attention Deficit and Disruptive Behavior Disorders. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Norway
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this clinical trial is to test if the invest in Play (iiP) parent program can reduce problem behaviors in children and improve parenting practices in families with children who show challenging behaviors. The main questions it aims to answer is: • Does the iiP program reduce children's problem behaviors? Researchers will compare families in the iiP program to families in a control group to see if the program leads to better outcomes for children and parents. Participants will be randomly assigned to either the iiP program group or the control group and complete surveys before and after the program to see if iiP is reducing children's problem behaviors.

Interventions

  • Behavioral Intervention
    The intervention group will receive Invest in Play (iiP), a 12 session group-based parent program, which is led by two trained group leaders.

Primary outcome measures

  • Change in the Eyberg Child Behavior Inventory (ECBI) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
Secondary outcome measures (8)
  • Change in the Social Competence Scale-Parent (SCS-P) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Kidscreen-10 score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in Strengths and Difficulties Questionnaire (SDQ) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Parenting and Family Adjustment Scales (PAFAS) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Parent Stress Scale (PSS) scores at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Parent Cognition Scale (PCS) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Me as parent - Short form (MaaPs-SF) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]
  • Change in the Parental Emotion Regulation Inventory (PERI-2) score at different time points (from baseline up to 12 weeks). [Time frame: From baseline to the end of treatment at 12 weeks.]

Eligibility criteria

Inclusion criteria

  • Parents of children between 6-12 years of age referred to out-patient clinics for treatment of behavioural problems.
  • Children scoring above a pre-defined mean cut off score (over the 90 percentile) on the Eyberg Child Behavior Inventory (ECBI; Eyberg \& Ross, 1978) based on Norwegian norms (Reedtz et al., 2008), as reported by parents.

Exclusion criteria

\- Severe developmental delay (in children or parents), autism spectrum disorder, inability to understand Norwegian, or other reasons why the parent(s) are not expected to benefit from group therapy.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Norway · 5 centers
  • Betanien Hospital — Bergen
  • Haukeland university hospital, department of mental health care for children and adolescen — Bergen
  • Helse Fonna HF, BUP Stord — Haugesund
  • Helse Nord-Trøndelag HF, Barne- og ungdomspsykiatrisk avdeling (BUP) — Namsos
  • OUS/PHA/BUPA/BUP Oslo Nord — Oslo

Identifiers

NCT: NCT06984809 · 2024/785387 · 2025-957314

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗